| CTRI Number |
CTRI/2025/08/092211 [Registered on: 01/08/2025] Trial Registered Prospectively |
| Last Modified On: |
01/08/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Cosmeceuitcal] |
| Study Design |
Other |
|
Public Title of Study
|
The Study to check the safety and effectiveness of product on human volunteers |
|
Scientific Title of Study
|
To evaluate and compare the in vivo safety and efficacy of Skin Care Formulations versus Untreated control in terms of the moisturization & skin water barrier function on healthy minor girls & boys subjects |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| XXX-HD01-4B-MY25; Version: 01; Dated: 23/07/2025 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Pooja Yadav |
| Designation |
Principal Investigator |
| Affiliation |
MASCOT-SPINCONTROL India Pvt. Ltd. |
| Address |
Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
Mumbai MAHARASHTRA 400025 India |
| Phone |
02243349191 |
| Fax |
|
| Email |
poojayadav@mascotspincontrol.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Pooja Yadav |
| Designation |
Principal Investigator |
| Affiliation |
MASCOT-SPINCONTROL India Pvt. Ltd. |
| Address |
Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
MAHARASHTRA 400025 India |
| Phone |
02243349191 |
| Fax |
|
| Email |
poojayadav@mascotspincontrol.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Mohit Lalvani |
| Designation |
Study Director |
| Affiliation |
MASCOT-SPINCONTROL India Pvt. Ltd. |
| Address |
Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
Mumbai MAHARASHTRA 400025 India |
| Phone |
02243349191 |
| Fax |
|
| Email |
mohit.CTRI@gmail.com |
|
|
Source of Monetary or Material Support
|
| Baby Forest Ayurveda Private Limited
A-55, BLOCK–A, SECTOR– 83, NOIDA DISTT. GAUTAMBUDH NAGAR a, 55, Sector 9, Noida, Uttar Pradesh 201301, India |
|
|
Primary Sponsor
|
| Name |
Baby Forest Ayurveda Private Limited |
| Address |
A-55, BLOCK–A, SECTOR– 83, NOIDA DISTT. GAUTAMBUDH NAGAR a, 55, Sector 9, Noida, Uttar Pradesh 201301, India |
| Type of Sponsor |
Other [Ayurvedic baby Care product Industry] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Pooja Yadav |
Mascot Spincontrol India Pvt. Ltd. |
Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra Mumbai MAHARASHTRA |
02243349191
poojayadav@mascotspincontrol.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethos- An Institutional Ethics committee (Mumbai) |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
having dry skin type |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Khilta Mukhra Baby Face Cream (BFFC/04) |
20 µl of the test product will be applied to randomized 3×3 cm² sites on the forearm. The product will be gently spread using a finger cot and left uncovered for absorption. Water should not be applied on site for 48 hours. |
| Intervention |
MOH MALAI BABY BODY LOTION (BFBL/03) |
20 µl of the test product will be applied to randomized 3×3 cm² sites on the forearm. The product will be gently spread using a finger cot and left uncovered for absorption. Water should not be applied on site for 48 hours. |
| Intervention |
Nikhrae Kesh Baby Shampoo (BFBS/05) |
20 µl of the test product will be applied to randomized 3×3 cm² sites on the forearm. The product will be gently spread using a finger cot and left uncovered for absorption. Water should not be applied on site for 48 hours. |
| Intervention |
Sampoorna Snan Baby Body Wash (BFBBW/06) |
20 µl of the test product will be applied to randomized 3×3 cm² sites on the forearm. The product will be gently spread using a finger cot and left uncovered for absorption. Water should not be applied on site for 48 hours. |
| Comparator Agent |
Untreated control site |
Another site of 3 × 3 cm² marked on the inner forearm is kept as an untreated control site. No product application is done on the untreated control site. |
|
|
Inclusion Criteria
|
| Age From |
12.00 Year(s) |
| Age To |
17.00 Year(s) |
| Gender |
Both |
| Details |
1)Indian girl & boys subjects.
2)Healthy subjects
3)Skin is healthy on the studied anatomic unit.
4)Subject having dry skin type.
|
|
| ExclusionCriteria |
| Details |
1. Having refused to give her/his assent by not signing the consent form
2. Taking part in another study liable to interfere with this study
3. Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months)
4. Having a progressive asthma (either under treatment or last fit in the last 2 years)
5. Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
6. Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
7. Being epileptic.
8. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories,
anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
9. Having cutaneous hypersensitivity.
10. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
11. Having undergone a surgery requiring a general anesthetic of more than one hour in the past 6
months. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Moisturization & skin water barrier function |
Baseline, 30 minutes, 24 Hours and 48 Hours after product application |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Nil |
NA |
|
|
Target Sample Size
|
Total Sample Size="66" Sample Size from India="66"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
12/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="0" Days="20" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
OBJECTIVE :
The objective of this study will be to evaluate and compare the in-vivo safety
and efficacy of Skin Care Formulations versus Untreated control in terms
of the moisturization & skin water barrier function on
healthy minor girls
& boys subjects.
The evaluation will
be performed using:Subject Self Evaluation
(SSE), Dermatological Evaluation: Cosmetic Acceptability, Dermatological
Evaluation : Efficacy, Corneometry, Tewametry
POPULATION :
66 minor girls & boys subjects will be selected for the study. The study
will be conducted in 2 groups 33 (16 boys & 17 girls / 17 boys & 16
girls) subjects in each group.
Group A: - Product A &
Product B
Group B: - Product C &
Product D
The subjects
selected for this study will be healthy minor aged between 12 and 17 years,
having dry skin type.
STUDY
DURATION : 48 hours following
the application of the product. |